Lv31
250 积分 2023-09-19 加入
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
9天前
已完结
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
9天前
已完结
Sevabertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer
28天前
已完结
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m2 but without diabetes: A phase 2 randomized controlled trial
1个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
1个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
1个月前
已完结
Sevabertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer
1个月前
已完结
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
1个月前
已完结
皖公网安备34019202002308
